Vitiligo Update
Seminars in Cutaneous Medicine and Surgery · 2009-06 · 28 (2) · 86-92
DOI: 10.1016/j.sder.2009.04.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cutaneous Medicine and Surgery, 2009-06. Verfasst von Rebat M Halder und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Howard University College of Medicine, Washington, DC 20060, USA. rhalder@howard.edu. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Vitiligo is an acquired dyschromia of the skin in which there is a loss of epidermal melanocytes. The prevalence of vitiligo is approximately 1% in the United States and 0.1-2% worldwide. The exact pathogenesis of vitiligo remains elusive and is likely multifactorial. After completing this update, participants should be able to discuss the epidemiology of vitiligo and summarize the proposed mechanisms for development of this disease. In addition, they should be able to discuss physical findings, approach to the patient, and some of the therapeutic modalities for this disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Howard University College of Medicine, Washington, DC 20060, USA. rhalder@howard.edu
Zitieren
APA
Halder, R. M., & Chappell, J. L. (2009). Vitiligo Update. Seminars in Cutaneous Medicine and Surgery, 28(2), 86-92. https://doi.org/10.1016/j.sder.2009.04.008
Vancouver
Halder RM, Chappell JL. Vitiligo Update. Seminars in Cutaneous Medicine and Surgery. 2009;28(2):86-92. doi:10.1016/j.sder.2009.04.008
BibTeX
@article{Halder2009,
author = {Halder, Rebat M and Chappell, Johnathan L},
title = {Vitiligo Update},
journal = {Seminars in Cutaneous Medicine and Surgery},
year = {2009},
volume = {28},
number = {2},
pages = {86--92},
doi = {10.1016/j.sder.2009.04.008}
}
EUVIMED